NeueHealth Statistics
Share Statistics
NeueHealth has 8.93M
shares outstanding. The number of shares has increased by 5.23%
in one year.
| Shares Outstanding | 8.93M |
| Shares Change (YoY) | 5.23% |
| Shares Change (QoQ) | 4.45% |
| Owned by Institutions (%) | 63.82% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 276 |
| FTD / Avg. Volume | 1.34% |
Short Selling Information
The latest short interest is 5.8K, so 0.06% of the outstanding
shares have been sold short.
| Short Interest | 5.8K |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.45 and the forward
PE ratio is -2.25.
NeueHealth's PEG ratio is
0.01.
| PE Ratio | -0.45 |
| Forward PE | -2.25 |
| PS Ratio | 0.07 |
| Forward PS | 0.1 |
| PB Ratio | -0.14 |
| P/FCF Ratio | -0.49 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for NeueHealth.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61,
with a Debt / Equity ratio of -0.47.
| Current Ratio | 0.61 |
| Quick Ratio | 0.61 |
| Debt / Equity | -0.47 |
| Debt / EBITDA | -2.53 |
| Debt / FCF | -1.63 |
| Interest Coverage | -5.46 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $949,956.39 |
| Profits Per Employee | $-136,592.29 |
| Employee Count | 986 |
| Asset Turnover | 1.72 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 2.6M |
| Effective Tax Rate | -2.61% |
Stock Price Statistics
The stock price has increased by 15.65% in the
last 52 weeks. The beta is 0.54, so NeueHealth's
price volatility has been higher than the market average.
| Beta | 0.54 |
| 52-Week Price Change | 15.65% |
| 50-Day Moving Average | 6.68 |
| 200-Day Moving Average | 6.08 |
| Relative Strength Index (RSI) | 51.26 |
| Average Volume (20 Days) | 20,558 |
Income Statement
In the last 12 months, NeueHealth had revenue of 936.66M
and earned -134.68M
in profits. Earnings per share was -22.65.
| Revenue | 936.66M |
| Gross Profit | 194.52M |
| Operating Income | -102.06M |
| Net Income | -134.68M |
| EBITDA | -80.76M |
| EBIT | -80.76M |
| Earnings Per Share (EPS) | -22.65 |
Full Income StatementBalance Sheet
The company has 83.3M in cash and 204.61M in
debt, giving a net cash position of -121.32M.
| Cash & Cash Equivalents | 83.3M |
| Total Debt | 204.61M |
| Net Cash | -121.32M |
| Retained Earnings | -4.44B |
| Total Assets | 895.68M |
| Working Capital | -275.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -123.22M
and capital expenditures -2.33M, giving a free cash flow of -125.55M.
| Operating Cash Flow | -123.22M |
| Capital Expenditures | -2.33M |
| Free Cash Flow | -125.55M |
| FCF Per Share | -15.26 |
Full Cash Flow StatementMargins
Gross margin is 20.77%, with operating and profit margins of -10.9% and -14.38%.
| Gross Margin | 20.77% |
| Operating Margin | -10.9% |
| Pretax Margin | -10.62% |
| Profit Margin | -14.38% |
| EBITDA Margin | -8.62% |
| EBIT Margin | -10.9% |
| FCF Margin | -13.4% |
